Insmed (INSM ) Presents At 2021 Jefferies Virtual Healthcare Conference - Slideshow

Promising Therapies Inspired by Urgent Unmet Patient Needs 2 of the Company, PARI or the Company's other third-party manufacturers to comply with regulatory requirements related to ARIKAYCE or the Lamira® Nebulizer System; the Company's inability to obtain adequate reimbursement from government or third-party payors for ARIKAYCE or acceptable prices for ARIKAYCE; development of unexpected safety or efficacy concerns related to ARIKAYCE or the Company's product candidates; inaccuracies in the Company's estim ...